Risperidone vs Olanzapine in Treatment of Schizophrenia: A Double Blind Clinical Trial

MOJ Addiction Medicine & Therapy
doi 10.15406/mojamt.2018.05.00095
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MedCrave Group, LLC


Related search